Preparation and Quality Evaluation of Honokiol Nanoparticles Using a New Polysaccharide Polymer as its Carrier

Author:

Xiong Yang12,Weng Ye31,Zhang Hongyan1,Xu Shujun1,Zhao Yue1,Ma Lisha1,Shi Jingbin1,Qian Ke1,Liang Weizong1

Affiliation:

1. School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China

2. Academy of Chinese Medical Science, Zhejiang Chinese Medical University, Hangzhou 310053, China

3. The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China

Abstract

Objective: To improve solubility of Honokiol (HNK), Honokiol nanoparticles (HNK-NPs) were prepared by using a new biodegradable polysaccharide polymer as its carrier. Methods: HNK-NPs were prepared by hydrophilic polymer coagulation method, and the processing parameters were optimized according to average particle size and PDI by single factor experiment. The morphology of the optimized nanoparticles was investigated by TEM and the in vitro release was carried out to evaluate the optimized HNK-NPs. Results: The encapsulation efficiency and drug loading of the HNK-NPs were 77.75 ± 2.63% and 13.46 ± 0.39%. The obtained nanoparticles of HNK-NPs were spherical-like under the electron microscope with a mean particle size of 198.50 ± 0.01 nm and Zeta potential of −52.60 ± 1.00 mV, respectively. The in vitro release results showed that the cumulative release rates of nanoparticles were 48.28 ± 9.80% and 81.12 ± 4.35% within 2 h and 8 h, respectively which showed a stable release behavior. The average particle size and PDI of HNK-NPs solution prepared by hydrophilic polymer condensation method had no obvious change at 72h. Conclusion: HNK-NPs were successfully prepared by phase separation method. This new polysaccharide polymer should be an ideal carrier to help improving the solubility of HNK.

Funder

National Natural Science Foundation of China

General research program of the Zhejiang Provincial Department of health

Zhejiang Chinese Medical University

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3